Differential effect of β-N-oxalylamino-L-alanine, the Lathyrus sativus neurotoxin, and (±)-α-amino-3-hydroxy-5-methylisoxazole-4-propionate on the excitatory amino acid and taurine levels in the brain of freely moving rats

Neurochemistry International

Volumn 36, Issue 6, 2000, Pages 523-530

  La Bella, Vincenzo ^a   Piccoli, Federico ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 3 OXALYLAMINOALANINE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 6,7 DINITRO 2,3 QUINOXALINEDIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ASPARTIC ACID; DIZOCILPINE; EXCITATORY AMINO ACID; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTOXIN; POTASSIUM CHLORIDE; TAURINE; TETRODOTOXIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; LATHYRISM; MALE; MOTOR CORTEX; NEUROTOXICITY; NONHUMAN; PHYTOTOXICITY; PLANT SEED; PRIORITY JOURNAL; RAT;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; AMINO ACIDS, DIAMINO; ANIMALS; ASPARTIC ACID; BETA-ALANINE; BRAIN; CORPUS STRIATUM; EXCITATORY AMINO ACID ANTAGONISTS; EXTRACELLULAR SPACE; GLUTAMIC ACID; MALE; MICRODIALYSIS; MOTOR CORTEX; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; TAURINE; TETRODOTOXIN;

EID: 0033956248     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(99)00152-7     Document Type: Article

References (44)

1. 2+-independent release of neurotransmitters. J. Neurochem. 58:1992;395-405.
2. Attwell D., Barbour B., Szatkowski M. Nonvesicular release of neurotransmitter. Neuron. 11:1993;401-407.
3. Cohn D.F., Streifler M. Human neurolathyrism, a follow-up of 200 patients. Part I: clinical investigation. Arch. Suisses Neurol. Neuroch. Psychiatr. 128:1981;151-156.
4. Curras M.C., Dingledine R. Selectivity of amino acid transmitters acting at N-methyl-D-aspartate and amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors. Mol. Pharmacol. 41:1992;520-526.
5. Duncan, M.W., Steele, J.C., Kopin, I.J., Markey, S.P., 1990 2-amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Neurology 40, 767-772.
6. Fyske E.M., Iversen E.G., Fonnum F. Inhibition of L-glutamate uptake into synaptic vesicles. Neurosci. Lett. 135:1992;125-128.
7. Haimanot R.T., Kidane Y., Wuhib E., Kalissa A., Alemu T., Zein Z.A., Spencer P.S. Lathyrism in rural northwestern Ethiopia: a highly prevalent neurotoxic disorder. Int. J. Epidemiol. 19:1990;664-672.
8. Herrera-Marschitz M., Meana J.J., O'Connor W.T., Goiny M., Reid M.S., Ungerstedt U. Neuronal dependence of extracellular dopamine, acetylcholine, glutamate, aspartate and GABA measured simultaneously from rat neostriatum using in vivo microdialysis reciprocal interactions. Amino Acids. 2:1992;157-169.
9. Huxtable R.J. Physiological actions of taurine. Physiol. Rev. 72:1992;101-163.
10. Kubrusly R.C.C., deMello M.C.F., deMello F.G. Aspartate as a selective NMDA receptor agonist in cultured cells from the avian retina. Neurochem. Int. 32:1998;47-52.
11. Kurland L.T. Amyotrophic lateral sclerosis and Parkinson's disease complex on Guam linked to an environmental neurotoxin. T.I.N.S. 11:1988;51-54.
12. La Bella V., Brighina F., Piccoli F., Guarneri R. Effect of β-N-oxalylamino-L-alanine on cerebellar cGMP level in vivo. Neurochem. Res. 18:1993;171-175.
13. 3H-glutamate binding in different areas of rat brain. Neurodegeneration. 2:1993;253-258.
14. La Bella V., Alexianu M.E., Colom L.V., Ionescu A., Mohamed A.H., Appel S.H. Apoptosis induced by β-N-oxalylamino-L-alanine on a motoneuron hybrid cell line. Neuroscience. 70:1996;1039-1052.
15. La Bella V., Rizza M.L., Alfano F., Piccoli F. Dietary consumption of Lathyrus sativus seeds induces behavioral changes in the rat. Environ. Res. 74:1997;61-66.
16. Liu D., McAdoo D.J. An experimental model combining microdialysis with electrophysiology, histology, and neurochemistry for exploring mechanisms of secondary damage in spinal cord injury: effects of potassium. J. Neurotrauma. 10:1993;349-362.
17. Ludolph A.C., Hugon J., Dwivedi M.P., Schaumburg H.H., Spencer P.S. Studies on the aetiology and pathogenesis of motor neuron disease. 1. Lathyrism: clinical findings in established cases. Brain. 110:1987;149-165.
18. Ludolph A.C., Spencer P.S. Toxic models of upper motor neuron disease. J. Neurol. Sci. 139:(suppl.):1996;53-59.
19. Makowske M., Christensen H.N. Contrasts in transport systems for anionic amino acids in hepatocytes and a hepatoma cell line HTC. J. Biol. Chem. 257:1982;711-760.
20. Massieu L., Morales-Villagran A., Tapia R. Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage: an in vivo microdialysis study. . J. Neurochem. 55:1995;714-717.
21. Menendez N., Solis J.M., Herreras O., Herranz A.S., Martin del Rio R. Role of endogenous taurine on the glutamate analogue-induced neurotoxicity in the rat hippocampus in vivo. J. Neurochem. 55:1990;714-717.
22. Miller S., Nunn P.B., Bridges R.J. Induction of astrocyte glutamine synthetase activity by the Lathyrus toxin β-N-oxalyl-L-α,β-diaminopropionic acid (β-L-ODAP). Glia. 7:1993;329-336.
23. Murphy T.H., Schuarr P.L., Coyle J.T. Immature cortical neurons are uniquely sensitive to glutamate neurotoxicity by inhibition of cystine uptake. Fedn. Am. Soc. Exp. Biol. (FASEB) J. 4:1990;1624-1633.
24. Nicholls D., Attwell D. The release and uptake of excitatory amino acids. Trends Pharmacol. Sci. 11:1990;462-468.
25. Pai K.S., Ravindranath V. L-BOAA induces selective inhibition of brain mitochondrial enzyme, NADH-dehydrogenase. Brain Res. 621:1993;215-221.
26. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1982;Academic Press, Sidney.
27. Rao S.L.N. Entry of beta-N-oxalyl-L-alpha,beta-diaminopropionic acid, the Lathyrus sativus neurotoxin into the central nervous system of the adult rat, chick and the rhesus monkey. J. Neurochem. 30:1978;1467-1470.
28. Ross S.M., Roy D.N., Spencer P.S. β-N-oxalylamino-L-alanine: action on high-affinity transport of neurotransmitters in rat brain and spinal cord synaptosomes. J. Neurochem. 44:1985;886-892.
29. Ross S.M., Roy D.N., Spencer P.S. β-N-oxalylamino-L-alanine action on glutamate receptors. J. Neurochem. 53:1989;710-715.
30. Sabri M.I., Lystrup B., Roy D.N., Spencer P.S. Action of β-N-oxalylamino-L-alanine on mouse brain NADH-dehydrogenase activity. J. Neurochem. 65:1995;1842-1848.
31. Sanchez-Carbente M., Massieu L. Transient inhibition of glutamate uptake in vivo induces neurodegeneration when energy metabolism is impaired. J. Neurochem. 72:1999;129-138.
32. Sawutz D.G., Krafte D.S., Oleynek J.J., Ault B. AMPA (amino-3-hydroxy-5-methylisoxazole-4-propionic acid) receptors in human brain tissues. J. Recept. & Sign. Transd. Res. 15:1995;829-846.
33. Segovia G., Delarw A., Mora F. Endogenous glutamate increases extracellular concentration of dopamine, GABA and taurine through NMDA and AMPA/Rainate receptors in striatum of the freely moving rat: A microanalysis study. J. Neurochem. 69:1997;1476-1483.
34. Seyle H. Lathyrism. Rev. Can. Biol. 16:1957;1-2.
35. Shibanoki S., Kogure M., Sugahara M., Ishikawa K. Effect of systemic administration of N-methyl-D-aspartic acid on extracellular taurine level measured by microdialysis in the hippocampal CA1 field and striatum of rats. J. Neurochem. 61:1993;1689-1704.
36. Spencer P.S. Are neurotoxins driving us crazy? Planetary observations on the causes of neurodegenerative diseases of old age. Russel R.W., Flattau P.E., Pope A.M. Behavioral Measures of Neurotoxicity. 1990;11-36 National Academic Press, Washington, DC.
37. Spencer P.S., Allen C.N., Kisby G.E., Ludolph A.C., Ross S.M., Roy D.N. Lathyrism and Western Pacific amyotrophic lateral sclerosis: etiology of short and long latency motor system disorders. Rowland L.P. Adv. Neurol. 56: Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases. 1991;287-299 Raven Press.
38. Spencer P.S., Ludolph A.C., Kisby G.E. Neurologic diseases associated with use of plant components with toxic potential. Environ. Res. 62:1993;106-113.
39. Spencer, P.S., Nunn, P.B., Hugon, J., Ludolph, A.C., Ross, S., Roy, D.N., Roberston, R.C., 1987 Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin, 237 517-522.
40. Streifler M., Cohn D.F., Hirano A., Schujman E. The central nervous system in a case of neurolathyrism. Neurology. 27:1977;1176-1178.
41. +: role of glia. Brain Res. 542:1991;259-265.
42. Vardhan K.S., Pratap Rudra M.P., Rao S.L.N. Inhibition of tyrosine aminotransferase by β-N-oxalyl-L-α,β-diaminopropionic acid, the Lathyrus sativus neurotoxin. J. Neurochem. 68:1997;2477-2484.
43. Zhou M., Peterson C.L., Lu Y.-B., Nadler J.V. Release of glutamate and aspartate from CA1 synaptosomes: selective modulation of aspartate release by ionotropic glutamate receptors ligands. J. Neurochem. 64:1995;1556-1566.
44. Willis C.L., Meldrum B.S., Nunn P.B., Anderton B.H., Leigh P.N. Neuroprotective effect of free radical scavengers on β-N-oxalylamino-L-alanine (BOAA)-induced neuronal damage in rat hippocampus. Neurosci. Lett. 182:1994;159-162.